0001683180-17-000004.txt : 20171220 0001683180-17-000004.hdr.sgml : 20171220 20171220172722 ACCESSION NUMBER: 0001683180-17-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171220 DATE AS OF CHANGE: 20171220 EFFECTIVENESS DATE: 20171220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jecure Therapeutics, Inc. CENTRAL INDEX KEY: 0001698655 IRS NUMBER: 811341025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-281127 FILM NUMBER: 171267524 BUSINESS ADDRESS: STREET 1: 3210 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-750-0045 MAIL ADDRESS: STREET 1: 3210 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 D/A 1 primary_doc.xml X0708 D/A LIVE 0001698655 Jecure Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 SAN DIEGO CA CALIFORNIA 92121 (619) 541-8699 DELAWARE None None Corporation true 2015 Jeffrey Stafford, Ph.D. c/o Jecure Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Director James Veal, Ph.D. c/o Jecure Therapeutics, Inc. 4757 Nexus Center Drive,Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Ariel Feldstein, M.D. c/o Jecure Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Thomas Woiwode, Ph.D. One Sansome Street, Suite 3630 San Francisco CA CALIFORNIA 94104 Director Bradley Bolzon, Ph.D. c/o Jecure Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 San Diego CA CALIFORNIA 94104 Director Biotechnology Decline to Disclose 06b true 0001698655-17-000001 2017-02-13 false true false 0 15025000 15023493 1507 Total Amount Sold includes the conversion of principal and interest under previously outstanding convertible promissory notes. false 4 0 0 0 false Jecure Therapeutics, Inc. /s/ Jeffrey A.Stafford Jeffrey A. Stafford, Ph.D. Chief Executive Officer 2017-12-19